Eli Lilly Brings a Coronavirus Drug Study Directly to Senior Care Facilities -- in RVs
Eli Lilly (NYSE: LLY) revealed Monday on its website that it has designed and built a fleet of traveling laboratories to support its COVID-19 research. Their first task: To bring a phase 3 clinical trial of its LY-CoV555 coronavirus antibody treatment candidate directly to the residents and staff of senior care facilities.
The pharmaceutical giant started its project by modifying Coachmen recreational vehicles; it now has an unspecified number of "mobile research units" (MRUs).
Image source: Getty Images.
Source Fool.com
